Literature DB >> 9741338

Activation-dependent expression of the insulin-like growth factor binding protein-2 in human lymphocytes.

J L Föll1, L Dannecker, C Zehrer, S Hettmer, J Berger, M Elmlinger, D Niethammer, M B Ranke, G E Dannecker.   

Abstract

The expression of the insulin-like growth factor binding protein-2 (IGFBP-2) was assayed in mononuclear cells originating from different organs of the immune system. All mononuclear cells studied did express IGFBP-2, but the expression level was found to be dependent on the cell type and origin of the cell. T cells showed a higher expression of IGFBP-2 mRNA than did B cells, and CD34+ stem cells expressed IGFBP-2 mRNA at a high level. Expression was highest in bone marrow and thymus. Stimulation of peripheral mononuclear cells resulted in a marked increase of IGFBP-2 mRNA and also intracellular IGFBP-2, as analysed by fluorescence staining. This increase parallels the increase of other known T-cell activation markers. Furthermore, the increase of intracellular IGFBP-2 seems to precede T-cell blast formation and all T cells in active phases of the cell cycle have high levels of IGFBP-2. Our results provide a basis for further investigations on the contribution of the IGF-system to the regulation of T-cell proliferation and differentiation. IGFBP-2, in particular, may have an important influence in the regulation of T-cell activation and proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741338      PMCID: PMC1364202          DOI: 10.1046/j.1365-2567.1998.00502.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

Review 1.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

Authors:  W H Daughaday; P Rotwein
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  A characteristic Mls-1a response precedes Mls-1a anergy in vivo.

Authors:  G Dannecker; S Mecheri; L Staiano-Coico; M K Hoffmann
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

3.  Immunogenic Ia-binding peptides immobilize the Ia molecule and facilitate its aggregation on the B cell membrane. Control by the M1s-1 gene.

Authors:  S Mecheri; M Edidin; G Dannecker; R S Mittler; M K Hoffmann
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

4.  The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes.

Authors:  T Nyman; F Pekonen
Journal:  Acta Endocrinol (Copenh)       Date:  1993-02

5.  Growth factors: mechanism of action and relation to oncogenes.

Authors:  C H Heldin; B Westermark
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

6.  Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4.

Authors:  E K Neely; S D Smith; R G Rosenfeld
Journal:  Acta Endocrinol (Copenh)       Date:  1991-06

7.  Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.

Authors:  M L Adamo; Z M Shao; F Lanau; J C Chen; D R Clemmons; C T Roberts; D LeRoith; J A Fontana
Journal:  Endocrinology       Date:  1992-10       Impact factor: 4.736

8.  Insulin-like growth-factor-binding protein gene expression and protein production by human tumour cell lines.

Authors:  J G Reeve; L B Kirby; A Brinkman; S A Hughes; J Schwander; N M Bleehen
Journal:  Int J Cancer       Date:  1992-07-09       Impact factor: 7.396

Review 9.  Structure, evolution, expression and regulation of insulin-like growth factors I and II.

Authors:  P Rotwein
Journal:  Growth Factors       Date:  1991       Impact factor: 2.511

10.  Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes.

Authors:  E W Johnson; L A Jones; R W Kozak
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

View more
  1 in total

1.  IGFBP2 function as a novel biomarker for active lupus nephritis.

Authors:  Hui Li; Jun Liang; Yingying Gao; Min Liu; Nan Xia; Wei Kong; Lisha Zheng; Yikun Zhang; Zutong Li; Hongwei Chen; Shanshan Liu; Lingyun Sun
Journal:  J Mol Med (Berl)       Date:  2022-08-25       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.